跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SPECTRILA 10000 U POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
SPECTRILA 10000 U POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Approved
STANDARD
SPECTRILA 10000 U POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Medac Gesellschaft Für Klinische Spezialpräparate Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 3, 2022
Approval ID
b03d9ebacf5392b2
Company
Medac Gesellschaft Für Klinische Spezialpräparate Gmbh
Type
Standard
Approval Details
Approval Id
b03d9ebacf5392b2
Drug Cima Aemps Name
SPECTRILA 10000 U POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number
1151072001
Holder Company Name
Medac Gesellschaft Für Klinische Spezialpräparate Gmbh
Marketing Company Name
Laboratorios Gebro Pharma S.A.
Authorization Date
2022-11-03
Dosage Form
POLVO PARA SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN
Dose
10000 U
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Medac Gesellschaft Für Klinische Spezialpräparate Gmbh
Active Ingredients
L-ASPARAGINASA RECOMBINANTE
10000 U
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 3, 2022
Approval ID
b03d9ebacf5392b2
Type
Standard
Back to CIMA-AEMPS Approvals